Prevalence Of Diabetic Nephropathy In The Urban Diabetic Population Of Mysuru
DOI:
https://doi.org/10.70082/rzqnzg29Keywords:
Diabetes Mellitus, Diabetic Nephropathy, Mysuru Urban population.Abstract
Aim: Diabetes Mellitus (DM) is becoming a serious public health concern in India, with increasing incidence in urban areas. Among its chronic complications, Diabetic nephropathy (DN) significantly contributes to morbidity and development to end-stage renal disease (ESRD). The goal of the study was to understand the prevalence and risk factors associated with diabetes complications, particularly nephropathy, in the urban Mysuru diabetic community.
Subject & Methods: Observational cross-sectional research was conducted among two hundred individuals diagnosed with type 2 diabetes(T2DM) from selected urban healthcare centres in Mysuru. Diabetic nephropathy was diagnosed based on the established criteria with data collected using structured questionnaires, clinical assessments, and laboratory investigations including HbA1c, and urine albumin. Statistical analysis was carried out to identify associations between nephropathy and demographic or clinical variables.
Results: Among the 200 participants, 54 (27%) were found to have DN. Significant associations were observed between nephropathy and older age (p = 0.001), extended duration of diabetes (p < 0.001), presence of hypertension (p < 0.001), poor glycaemic control (average HbA1c 8.8% vs. 7.8%, p < 0.001), and smoking (p = 0.03). Gender and BMI did not significantly associate with nephropathy.
Conclusion: The current study demonstrates a higher prevalence of DN in the urban diabetic population of Mysuru. Early screening, lifestyle modification, and aggressive management of blood pressure and glucose are suggested to reduce the burden of complications. These findings call for targeted urban public health strategies for diabetes management and complication prevention.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
